Hyperuricemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
196
|
76
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Finding of body mass index
|
phenotype |
|
Finding
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Waist Circumference
|
phenotype |
|
Clinical Attribute
|
70
|
183
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Body mass index procedure
|
phenotype |
|
Diagnostic Procedure
|
88
|
252
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Physical Activity Measurement
|
phenotype |
|
Laboratory Procedure
|
160
|
355
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Round cell sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
20
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Osteosarcoma of bone
|
disease |
Neoplasms
|
Neoplastic Process
|
2247
|
151
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Pilocytic Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
92
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Progressive pseudorheumatoid dysplasia
|
disease |
Musculoskeletal Diseases
|
Congenital Abnormality
|
64
|
27
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pulmonary Cystic Fibrosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
53
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Atrophic endometrium
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Pilocytic Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
163
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Regular astigmatism - corneal
|
disease |
Eye Diseases
|
Disease or Syndrome
|
34
|
28
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Complications of Diabetes Mellitus
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
240
|
35
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |